ACRS
Price
$2.07
Change
+$0.01 (+0.49%)
Updated
Sep 4 closing price
Capitalization
224.25M
61 days until earnings call
BJDX
Price
$1.41
Change
-$0.05 (-3.42%)
Updated
Sep 4 closing price
Capitalization
2.11M
Interact to see
Advertisement

ACRS vs BJDX

Header iconACRS vs BJDX Comparison
Open Charts ACRS vs BJDXBanner chart's image
Aclaris Therapeutics
Price$2.07
Change+$0.01 (+0.49%)
Volume$763.02K
Capitalization224.25M
Bluejay Diagnostics
Price$1.41
Change-$0.05 (-3.42%)
Volume$179.81K
Capitalization2.11M
ACRS vs BJDX Comparison Chart in %
Loading...
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BJDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACRS vs. BJDX commentary
Sep 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRS is a Buy and BJDX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2025
Stock price -- (ACRS: $2.07 vs. BJDX: $1.41)
Brand notoriety: ACRS and BJDX are both not notable
ACRS represents the Biotechnology, while BJDX is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ACRS: 77% vs. BJDX: 8%
Market capitalization -- ACRS: $224.25M vs. BJDX: $2.11M
ACRS [@Biotechnology] is valued at $224.25M. BJDX’s [@Medical/Nursing Services] market capitalization is $2.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.77B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.15B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACRS’s FA Score shows that 1 FA rating(s) are green whileBJDX’s FA Score has 0 green FA rating(s).

  • ACRS’s FA Score: 1 green, 4 red.
  • BJDX’s FA Score: 0 green, 5 red.
According to our system of comparison, ACRS is a better buy in the long-term than BJDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACRS’s TA Score shows that 4 TA indicator(s) are bullish while BJDX’s TA Score has 4 bullish TA indicator(s).

  • ACRS’s TA Score: 4 bullish, 4 bearish.
  • BJDX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ACRS and BJDX are a good buy in the short-term.

Price Growth

ACRS (@Biotechnology) experienced а +12.50% price change this week, while BJDX (@Medical/Nursing Services) price change was +2.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +14.47%, and the average quarterly price growth was +30.31%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.37%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +24.20%.

Reported Earning Dates

ACRS is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Medical/Nursing Services (-0.37% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACRS($224M) has a higher market cap than BJDX($2.11M). ACRS YTD gains are higher at: -16.532 vs. BJDX (-71.047). BJDX has higher annual earnings (EBITDA): -6.36M vs. ACRS (-57.87M). ACRS has more cash in the bank: 99.8M vs. BJDX (4.44M). ACRS has higher revenues than BJDX: ACRS (16.8M) vs BJDX (0).
ACRSBJDXACRS / BJDX
Capitalization224M2.11M10,631%
EBITDA-57.87M-6.36M910%
Gain YTD-16.532-71.04723%
P/E RatioN/A0.00-
Revenue16.8M0-
Total Cash99.8M4.44M2,246%
Total DebtN/A172K-
FUNDAMENTALS RATINGS
ACRS: Fundamental Ratings
ACRS
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
PROFIT vs RISK RATING
1..100
99
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
19

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACRSBJDX
RSI
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
76%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
77%
Declines
ODDS (%)
Bearish Trend 18 days ago
84%
Bearish Trend 23 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ACRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BJDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCI47.151.20
+2.61%
Transcontinental Realty Investors
CPBI16.270.03
+0.18%
Central Plains Bancshares
WLGS11.00N/A
N/A
Wang & Lee Group
CMPO18.56-0.36
-1.90%
CompoSecure
OKLO69.61-2.62
-3.63%
Oklo Inc.

ACRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACRS has been loosely correlated with MYNZ. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ACRS jumps, then MYNZ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACRS
1D Price
Change %
ACRS100%
+0.49%
MYNZ - ACRS
40%
Loosely correlated
+1.20%
IBRX - ACRS
34%
Loosely correlated
+0.84%
ITRM - ACRS
34%
Loosely correlated
+0.48%
ARCT - ACRS
31%
Poorly correlated
-2.50%
PDSB - ACRS
31%
Poorly correlated
-6.15%
More

BJDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BJDX has been loosely correlated with ALUR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BJDX jumps, then ALUR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BJDX
1D Price
Change %
BJDX100%
-3.42%
ALUR - BJDX
44%
Loosely correlated
+0.24%
CATX - BJDX
33%
Loosely correlated
+4.73%
ACRS - BJDX
29%
Poorly correlated
+0.49%
CVRX - BJDX
26%
Poorly correlated
-1.53%
ATRC - BJDX
22%
Poorly correlated
+2.56%
More